自身免疫性疾病与镰状细胞贫血:交叉通路与鉴别诊断
本文综述镰状细胞病(SCD)与自身免疫性疾病(AD)的现有文献,描述可区分SCD与系统性红斑狼疮、类风湿关节炎等AD的特征,旨在帮助临床血液科医生通过正确解读临床评估和常用诊断检查,更快速地诊断镰状细胞贫血患者的AD。
要点
- SCD的多系统表现可重叠AD临床特征,临床鉴别困难。
- 诊断延迟导致症状未治疗,且两者治疗差异大。
- 熟悉AD与SCD的临床和实验室结果可帮助医生避免诊断延迟。
核心结论
- 通过正确解读临床评估和常用诊断检查,临床血液科医生可更快速诊断镰状细胞贫血患者的AD。
研究设计与样本
- 综述,检索现有关于SCD与AD的文献。
主要发现
- SCD为单基因突变所致遗传病,有多系统表现,影响全球数百万人。
- SCD对关节和肌肉的影响可与AD临床特征重叠,临床难以区分。
- 诊断延迟导致症状未治疗,且SCD与AD治疗差异很大。
- 准确掌握AD与SCD的临床和实验室结果可帮助医生避免诊断延迟。
关键数值与推荐
- 描述了可区分SCD与系统性红斑狼疮、类风湿关节炎等AD的特征。
临床怎么用
- 作者旨在指导临床血液科医生通过正确解读临床评估和常用诊断检查,更快速诊断镰状细胞贫血患者的AD。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sickle cell disease (SCD) is an inherited disorder, which occurs due to a single gene mutation. It has multisystemic manifestations, affecting millions of people worldwide. The effect of SCD on joints and musculature can overlap with clinical features of autoimmune disease (AD). It is therefore difficult for clinical haematologists and physicians treating SCD patients to discriminate between these two conditions clinically. A delay in diagnosis leads to untreated symptoms and treatment differs considerably. An accurate knowledge of clinical findings and laboratory results of AD and SCD can help physicians avoid this. In the review that follows, we examine the existing literature on SCD and AD, and describe the features that may distinguish SCD and autoimmune disease such as systemic lupus erythematosus and rheumatoid arthritis. We aim to guide clinical haematologists and physicians towards a more rapid diagnosis of AD in sickle cell anaemia patients, by correct interpretation of the clinical assessment and commonly available diagnostics.
引用
- Piccin A, O'Connor-Byrne N, Daves M, et al. Autoimmune disease and sickle cell anaemia: 'Intersecting pathways and differential diagnosis'. Br J Haematol. 2022. PMID: 35244209. doi:10.1111/bjh.18109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。